dTpa Fact Sheet
... Bordetella pertussis. The disease begins like a cold and then the characteristic cough develops. This cough may last up to three months, even after antibiotic treatment is completed and the person is no longer infectious. The 'whoop' (which is not always obvious) is due to a deep breath at the end o ...
... Bordetella pertussis. The disease begins like a cold and then the characteristic cough develops. This cough may last up to three months, even after antibiotic treatment is completed and the person is no longer infectious. The 'whoop' (which is not always obvious) is due to a deep breath at the end o ...
Tetanus and Diphtheria Zoster (Shingles) MMR Varicella
... bacteria. For most, live vaccines are very safe, but must be used with caution in people with weakened immune systems. Non-live or inactivated vaccines are made from viruses and bacteria that have been killed through physical or chemical processes. These vaccines cannot replicate or cause infection. ...
... bacteria. For most, live vaccines are very safe, but must be used with caution in people with weakened immune systems. Non-live or inactivated vaccines are made from viruses and bacteria that have been killed through physical or chemical processes. These vaccines cannot replicate or cause infection. ...
The Immune System and Immunisation
... inactivated by heat or chemicals but remain antigenic. • They are usually safe but less effective than live attenuated vaccines. • Larger doses and more boosters are required. • Eg polio virus ...
... inactivated by heat or chemicals but remain antigenic. • They are usually safe but less effective than live attenuated vaccines. • Larger doses and more boosters are required. • Eg polio virus ...
Kirsanova T
... Rotavirus is one of the leading causes of a severe diarrhea leading to dehydration in infants. Most children are infected with these highly contagious viruses before they reach the age of 5 (according to numerous European studies to 80-85% of children of five years of life in blood has IgG to rotavi ...
... Rotavirus is one of the leading causes of a severe diarrhea leading to dehydration in infants. Most children are infected with these highly contagious viruses before they reach the age of 5 (according to numerous European studies to 80-85% of children of five years of life in blood has IgG to rotavi ...
3 Treating disease
... in a variety of different antibodies against a specific antigen. Monoclonal antibodies (mAbs) are antibodies produced from clones of a single plasma cell and are therefore all identical. They have many important uses, such as: ...
... in a variety of different antibodies against a specific antigen. Monoclonal antibodies (mAbs) are antibodies produced from clones of a single plasma cell and are therefore all identical. They have many important uses, such as: ...
Presentation slides - Yale School of Medicine
... • infects via anal/vaginal epithelia • replication/residence in immune cells • killed/attenuated virus • recombinant envelope glycoprotein • poor protection, cumbersome trials >80 million infected individuals/victims ...
... • infects via anal/vaginal epithelia • replication/residence in immune cells • killed/attenuated virus • recombinant envelope glycoprotein • poor protection, cumbersome trials >80 million infected individuals/victims ...
Flu - PassportHealthTexas.com
... Influenza (flu) is a respiratory disease caused by influenza virus infection. The types or strains, of influenza virus that cause illness may change from year to year, or even within the same year. People who get flu may have fever, chills, headache, dry cough, and muscle aches, and may be sick for ...
... Influenza (flu) is a respiratory disease caused by influenza virus infection. The types or strains, of influenza virus that cause illness may change from year to year, or even within the same year. People who get flu may have fever, chills, headache, dry cough, and muscle aches, and may be sick for ...
Kineta Scientists Present Novel Antiviral Research Findings at
... SEATTLE, WA, October 3, 2011 – Today, Kineta scientists will present new findings from the company’s antiviral drug development program – vaccine adjuvants of the Retinoic Acid Inducible Gene I (RIG-I), at the Fifth Annual International Society for Vaccines, Global Congress, in Seattle. Research sci ...
... SEATTLE, WA, October 3, 2011 – Today, Kineta scientists will present new findings from the company’s antiviral drug development program – vaccine adjuvants of the Retinoic Acid Inducible Gene I (RIG-I), at the Fifth Annual International Society for Vaccines, Global Congress, in Seattle. Research sci ...
Summary - Discontools
... M.hyorhinis and M. hyosynoviae. Mycoplamas may have various antigenic forms although these have never been formally classified. M. hyopneumoniae is the primary causative agent of enzootic pneumonia, which is historically one of the most common chronic respiratory diseases of swine. M. hyorhinis can ...
... M.hyorhinis and M. hyosynoviae. Mycoplamas may have various antigenic forms although these have never been formally classified. M. hyopneumoniae is the primary causative agent of enzootic pneumonia, which is historically one of the most common chronic respiratory diseases of swine. M. hyorhinis can ...
"Are your children 11-19 years old?"
... most cases of cervical cancer. Gardasil and Gardasil 9 also protect against additional types of HPV that cause most cases of genital warts. • Gardasil and Gardasil 9 are given in a 3-dose series starting at age 11 or 12. It can be given from ages 9 to 26. They are approved for both males and fem ...
... most cases of cervical cancer. Gardasil and Gardasil 9 also protect against additional types of HPV that cause most cases of genital warts. • Gardasil and Gardasil 9 are given in a 3-dose series starting at age 11 or 12. It can be given from ages 9 to 26. They are approved for both males and fem ...
Mucosal Immunization Technologies
... enzymatic degradation, and low pH in the stomach. These and other factors can limit the ability of the vaccine to reach its target immune cells, resulting in a suboptimal immune response. To more effectively protect people from pathogens that enter the body via the mucosa, new technological approach ...
... enzymatic degradation, and low pH in the stomach. These and other factors can limit the ability of the vaccine to reach its target immune cells, resulting in a suboptimal immune response. To more effectively protect people from pathogens that enter the body via the mucosa, new technological approach ...
Document
... a. Neutralizing Antibodies (Humoral Immunity) – block HIV bonding to CD4 b. Cellular Immunity – killer T-cells destroy infected helper T-cells 3. Discovered b/c some Kenyan sex workers seem naturally immune to transmission despite high exposure.ii – Rowland-Jones a. Linked to HIV-specific cytotoxic ...
... a. Neutralizing Antibodies (Humoral Immunity) – block HIV bonding to CD4 b. Cellular Immunity – killer T-cells destroy infected helper T-cells 3. Discovered b/c some Kenyan sex workers seem naturally immune to transmission despite high exposure.ii – Rowland-Jones a. Linked to HIV-specific cytotoxic ...
IMMUNOPROPHYLAXIS: Vaccines and Immunotherapy 2014
... immunologic protection against infectious agents. • Types of Immunizations 1. Active – exposure to antigen with the host generating protective immunity. • Objective: provide long lasting immunity against future exposures ...
... immunologic protection against infectious agents. • Types of Immunizations 1. Active – exposure to antigen with the host generating protective immunity. • Objective: provide long lasting immunity against future exposures ...
HIV Vaccine
... Other Inactivated Vaccines now contain purified proteins rather than whole bacteria/viruses ...
... Other Inactivated Vaccines now contain purified proteins rather than whole bacteria/viruses ...
AIDS Vaccine
... Other Inactivated Vaccines now contain purified proteins rather than whole bacteria/viruses ...
... Other Inactivated Vaccines now contain purified proteins rather than whole bacteria/viruses ...
2.11.15 - WordPress.com
... T cell-dependent activation 1. The T cell is stimulated to produce autocrines, resulting in the proliferation or differentiation to effector or memory T cells. 2. A certain portion of the resulting effector T cells then activate specific B cells through ...
... T cell-dependent activation 1. The T cell is stimulated to produce autocrines, resulting in the proliferation or differentiation to effector or memory T cells. 2. A certain portion of the resulting effector T cells then activate specific B cells through ...
Parliamentary Advisory Council on Science and Technology
... There are two basic mechanisms for acquiring immunity: passive and active immunity. Passive immunity consists in receiving antibodies produced by humans (e.g. in blood transfusions, in which, in addition to blood cells, immunoglobulins can also be transmitted) or from other sources. This type of imm ...
... There are two basic mechanisms for acquiring immunity: passive and active immunity. Passive immunity consists in receiving antibodies produced by humans (e.g. in blood transfusions, in which, in addition to blood cells, immunoglobulins can also be transmitted) or from other sources. This type of imm ...
Hepatitis B Vaccine Declination (Mandatory) I, , understand that due
... Hepatitis B Vaccine Declination (Mandatory) ...
... Hepatitis B Vaccine Declination (Mandatory) ...
Correlates of Immune Protection
... • Absolute Correlate: A specific level of response highly correlated with protection: a threshold • Relative Correlate: Level of response variably correlated with protection • Co-Correlate:One of two or more factors that • correlate with protection in alternative, additive, or synergistic ways. ...
... • Absolute Correlate: A specific level of response highly correlated with protection: a threshold • Relative Correlate: Level of response variably correlated with protection • Co-Correlate:One of two or more factors that • correlate with protection in alternative, additive, or synergistic ways. ...
File
... due to better nutrition (with rapid delivery of fresh fruit and vegetables to cities and refrigeration), cleaner water and improved sanitation (removing trash from the streets and better sewage systems), not to vaccines. The World Health Organization promotes mass vaccination, but knowing these fact ...
... due to better nutrition (with rapid delivery of fresh fruit and vegetables to cities and refrigeration), cleaner water and improved sanitation (removing trash from the streets and better sewage systems), not to vaccines. The World Health Organization promotes mass vaccination, but knowing these fact ...
APPENDIX B
... blood or other potentially infectious materials I may be at risk of acquiring hepatitis B virus (HBV) infection. I have been given the opportunity to be vaccinated with hepatitis B vaccine, at no charge to myself. However, I decline hepatitis B vaccination at this time. I understand that by declinin ...
... blood or other potentially infectious materials I may be at risk of acquiring hepatitis B virus (HBV) infection. I have been given the opportunity to be vaccinated with hepatitis B vaccine, at no charge to myself. However, I decline hepatitis B vaccination at this time. I understand that by declinin ...
LMC model, Hepatitis B - League of Minnesota Cities
... Hepatitis B Vaccination Declination Form I understand that due to my occupational exposure to blood or other potentially infectious materials I may be at risk of acquiring Hepatitis B virus (HBV) infection. I have been given the opportunity to be vaccinated with Hepatitis B vaccine, at no charge to ...
... Hepatitis B Vaccination Declination Form I understand that due to my occupational exposure to blood or other potentially infectious materials I may be at risk of acquiring Hepatitis B virus (HBV) infection. I have been given the opportunity to be vaccinated with Hepatitis B vaccine, at no charge to ...
HEPATITIS B VACCINE DECLINATION
... I understand that due to my occupational exposure to blood or other infectious materials that I may be at risk of acquiring Hepatitis B virus infection. I have been given the opportunity to be vaccinated with the Hepatitis B vaccination at this time. I understand that by declining this vaccine, I co ...
... I understand that due to my occupational exposure to blood or other infectious materials that I may be at risk of acquiring Hepatitis B virus infection. I have been given the opportunity to be vaccinated with the Hepatitis B vaccination at this time. I understand that by declining this vaccine, I co ...
Slide 1
... Organisms are killed or inactivated by heat or chemicals but remain antigenic. They are usually safe but less effective than live attenuated vaccines. The only absolute contraindication to their administration is a severe local or general reaction to a previous dose. ...
... Organisms are killed or inactivated by heat or chemicals but remain antigenic. They are usually safe but less effective than live attenuated vaccines. The only absolute contraindication to their administration is a severe local or general reaction to a previous dose. ...
Vaccine
A vaccine is a biological preparation that provides active acquired immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing micro-organism and is often made from weakened or killed forms of the microbe, its toxins or one of its surface proteins. The agent stimulates the body's immune system to recognize the agent as a threat, destroy it, and keep a record of it, so that the immune system can more easily recognize and destroy any of these micro-organisms that it later encounters.The administration of vaccines is called vaccination. The effectiveness of vaccination has been widely studied and verified; for example, the influenza vaccine, the HPV vaccine, and the chicken pox vaccine. Vaccination is the most effective method of preventing infectious diseases; widespread immunity due to vaccination is largely responsible for the worldwide eradication of smallpox and the restriction of diseases such as polio, measles, and tetanus from much of the world. The World Health Organization (WHO) reports that licensed vaccines are currently available to prevent or contribute to the prevention and control of twenty-five infections.Vaccines can be prophylactic (example: to prevent or ameliorate the effects of a future infection by any natural or ""wild"" pathogen), or therapeutic (e.g., vaccines against cancer are also being investigated; see cancer vaccine).The terms vaccine and vaccination are derived from Variolae vaccinae (smallpox of the cow), the term devised by Edward Jenner to denote cowpox. He used it in 1798 in the long title of his Inquiry into the...Variolae vaccinae...known...[as]...the Cow Pox, in which he described the protective effect of cowpox against smallpox. In 1881, to honour Jenner, Louis Pasteur proposed that the terms should be extended to cover the new protective inoculations then being developed.